The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
517 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $100,959,328 in first-year total cost, median $199,610.
Most frequent study sections
- Special Emphasis Panel[ZCA1 RTRB-F (O1)]21
- Special Emphasis Panel[ZCA1 SRB-2 (O1)]19
- Special Emphasis Panel[ZCA1 RPRB-J (J1)]17
- Special Emphasis Panel[ZCA1 SRB-2 (J1)]16
- Special Emphasis Panel[ZCA1 RPRB-0 (O1)]15
Most frequent institutions
- UNIVERSITY OF TX MD ANDERSON CAN CTR14
- DUKE UNIVERSITY12
- SLOAN-KETTERING INST CAN RESEARCH12
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO12
- YALE UNIVERSITY12
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2016 | Targeting RIP3-mediated Necroptosis for Chemosensitization1R21CA193633-01A1 | LIN, YONG | LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE, NM | $278,415 | ZCA1 |
| 2016 | Regulation of multiple myeloma by S100A9 protein1R21CA195020-01A1 | NEFEDOVA, YULIAVOGL, DAN TOBY | WISTAR INSTITUTE, PA | $259,949 | ZCA1 |
| 2016 | Managing chemotherapy induced neuropathy in Cancer patients using ExerGaming1R21CA190933-01A1 | GARLAND, LINDA LEENAJAFI, BIJAN | BAYLOR COLLEGE OF MEDICINE, TX | $259,412 | ZCA1 |
| 2016 | Exploiting the ERRalpha/PGC Axis for Cancer Therapy1R21CA190924-01A1 | LADEROUTE, KEITH R. | SRI INTERNATIONAL, CA | $258,166 | ZCA1 |
| 2016 | National trends in end of life care for adolescent and young adult cancer patients1R21CA205309-01 | WERNLI, KAREN J | KAISER FOUNDATION HEALTH PLAN OF WASHINGTON, WA | $256,238 | ZCA1 |
| 2016 | Role of Follicular Dendritic Cells in B lymphoma1R21CA195431-01A1 | RICKERT, ROBERT C | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA | $254,475 | ZCA1 |
| 2016 | Allosteric inhibition of the SHP2 oncoprotein in breast cancer1R21CA195422-01A1 | TAUTZ, LUTZ | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA | $254,475 | ZCA1 |
| 2016 | Methods for controlling small RNA stability1R21CA201861-01 | MACRAE, IAN JOHN | SCRIPPS RESEARCH INSTITUTE, THE, CA | $251,213 | ZCA1 |
| 2016 | Disparities in Abnormal Mammogram Follow-up: Actionable Communication and Care Coordination Strategies1R21CA195429-01A1 | KARLINER, LEAH S | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $241,316 | ZCA1 |
| 2016 | Multiplexed exosome analyses with DNA barcoding1R21CA205322-01 | LEE, HAKHO | MASSACHUSETTS GENERAL HOSPITAL, MA | $239,828 | ZCA1 |
| 2016 | Proton minibeams: Overcoming proton beams inability to spare superficial tissues1R21CA191818-01A1 | DILMANIAN, F AVRAHAMELEY, JOHN G.KRISHNAN, SUNIL | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $235,488 | ZCA1 |
| 2016 | Symptom progress and adverse health outcomes in adult childhood cancer survivors1R21CA202210-01 | HUANG, I-CHANKRULL, KEVIN R | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, TN | $233,106 | ZCA1 |
| 2016 | Role of ThPOK in HSC Maintenance and Leukemogenesis1R21CA195356-01A1 | KAPPES, DIETMAR JSYKES, STEPHEN MATTHEW | RESEARCH INST OF FOX CHASE CAN CTR, PA | $232,943 | ZCA1 |
| 2016 | Biological Effects of Systematic Light Exposure For Cancer-Related Fatigue1R21CA195164-01A1 | REDD, WILLIAM H | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $231,025 | ZCA1 |
| 2016 | Restoration of lymphatic function in postsurgical lymphedema with lymph node transfer1R21CA194882-01A1 | MEHRARA, BABAK J | SLOAN-KETTERING INST CAN RESEARCH, NY | $229,550 | ZCA1 |
| 2016 | Assessing the impact of differing pharmacy tobacco retail displays on smokers awareness, perceptions, and intentions to quit1R21CA198824-01A1 | BANSAL-TRAVERS, MAANSI | ROSWELL PARK CANCER INSTITUTE CORP, NY | $227,201 | ZCA1 |
| 2016 | Minimally invasive image-guided tumor ablation in an oncogenic pig model1R21CA195433-01A1 | BURDETTE, EVERETTE CRUND, LAURETTA | ACOUSTIC MEDSYSTEMS, INC., IL | $225,795 | ZCA1 |
| 2016 | Targeting of Tyrosine Phosphatase SHP2 in Myeloproliferative Neoplasms1R21CA202544-01 | MOHI, GOLAM | UPSTATE MEDICAL UNIVERSITY, NY | $224,929 | ZCA1 |
| 2016 | Modeling the impact of mutations in ubiquitin ligase genes on transcriptional programs in endometrial cancer1R21CA205819-01 | LESLIE, CHRISTINA S | SLOAN-KETTERING INST CAN RESEARCH, NY | $223,677 | ZCA1 |
| 2016 | Epigenomic Signatures of Radiation Sensitivity in HPV-associated Cancers1R21CA185921-01A1 | SHIBATA, DAVIDSIEGEL, ERIN | UNIVERSITY OF TENNESSEE HEALTH SCI CTR, TN | $223,484 | ZCA1 |
| 2016 | Pancreatic Cyst Fluid miRNOME for Biomarkers of Pancreatic Cancer1R21CA185962-01A1 | SEN, SUBRATA | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $223,369 | ZCA1 |
| 2016 | Reprogramming of Prostate Stromal Cells by Prostate Inflammation1R21CA196570-01A1 | XIN, LI | BAYLOR COLLEGE OF MEDICINE, TX | $222,296 | ZCA1 |
| 2016 | Novel Protein Risk Markers for Lung Cancer1R21CA195110-01A1 | PERERA, FREDERICA P | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $221,850 | ZCA1 |
| 2016 | Building personalized avatars of human cancer to predict response to therapy1R21CA202540-01 | HOUVRAS, YARIV J | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $221,198 | ZCA1 |
| 2016 | Development of novel RAS inhibitory agents for cancer therapy1R21CA201717-01 | O'BRYAN, JOHN P | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $220,888 | ZCA1 |
| 2016 | Efficacy of A Behavioral Intervention to Reduce Skin Cancer Risk Among Patients1R21CA196924-01A1 | MALLETT, KIMBERLY A | PENNSYLVANIA STATE UNIVERSITY, THE, PA | $220,298 | ZCA1 |
| 2016 | Comparative Effectiveness of Genomics Assay for Active Surveillance Failure Prediction in African American Men: the impact of genetic ancestry and socioeconomic status.1R21CA202552-01 | MURPHY, ADAM BRYANT | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $220,289 | ZCA1 |
| 2016 | Inhibition of the CMG Helicase as Novel Anti-Neoplastic Approach1R21CA187513-01A1 | ALEXANDROW, MARK G. | H. LEE MOFFITT CANCER CTR & RES INST, FL | $219,893 | ZCA1 |
| 2016 | ANOIKIS EFFECTORS AS DRIVERS OF METASTATIC MELANOMA1R21CA195077-01A1 | WAJAPEYEE, NARENDRA | YALE UNIVERSITY, CT | $217,826 | ZCA1 |
| 2016 | KRas Ligand Development1R21CA201986-01 | CREWS, CRAIG M | YALE UNIVERSITY, CT | $217,826 | ZCA1 |
| 2016 | Surfactant lipids and associated proteins in radiation-induced mucositis1R21CA202751-01 | LICHTENBERGER, LENARD M | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | $216,743 | ZCA1 |
| 2016 | ADAM8 Is a Novel Target for Treatment of Triple-Negative Breast Cancer1R21CA194955-01A1 | SONENSHEIN, GAIL E. | TUFTS UNIVERSITY BOSTON, MA | $215,325 | ZCA1 |
| 2016 | Improving Pediatric Tobacco Control in Primary Care1R21CA192950-01A1 | MAYS, DARREN MTERCYAK, KENNETH | GEORGETOWN UNIVERSITY, DC | $214,982 | ZCA1 |
| 2016 | Improving targeted colorectal cancer screening in the elderly1R21CA191454-01A1 | LEWIS, CARMEN LYNN | UNIVERSITY OF COLORADO DENVER, CO | $213,872 | ZCA1 |
| 2016 | CRISPR/Cas9-based lineage tracing for fate mapping of cancer cells and stem cells1R21CA205825-01 | LI, ZHE | BRIGHAM AND WOMEN'S HOSPITAL, MA | $212,575 | ZCA1 |
| 2016 | Targeting CXCR5 for angioimmunoblastic T-cell lymphoma1R21CA202525-01 | LOLIS, ELIAS | YALE UNIVERSITY, CT | $212,223 | ZCA1 |
| 2016 | RPTP domains regulating homodimerization and EGFR activity via heterodimerization1R21CA195158-01A1 | THEVENIN, DAMIEN | LEHIGH UNIVERSITY, PA | $211,914 | ZCA1 |
| 2016 | Chemogenomic Profiling of a Novel RNA Polymerase I Inhibitor1R21CA193637-01A1 | LAIHO, MARIKKI | JOHNS HOPKINS UNIVERSITY, MD | $211,410 | ZCA1 |
| 2016 | Longitudinal outcomes of serrated polyps: a population based study1R21CA191651-01A1 | AMOS, CHRISTOPHER I.BUTTERLY, LYNN F | DARTMOUTH COLLEGE, NH | $211,410 | ZCA1 |
| 2016 | Detection of High Grade Prostate Cancer with Subharmonic Ultrasound Imaging1R21CA202214-01 | FORSBERG, FLEMMINGHALPERN, ETHAN J | THOMAS JEFFERSON UNIVERSITY, PA | $209,434 | ZCA1 |
| 2016 | Mediator Kinases and AML Cell Proliferation1R21CA205912-01 | OLD, WILLIAM MARLANDTAATJES, DYLAN J | UNIVERSITY OF COLORADO, CO | $208,967 | ZCA1 |
| 2016 | KRAS Muations in Plasma cfDNA as Predictor to Erolinib Response in Advanced Pancreatic Cancer1R21CA202487-01 | LI, DONGHUIOVERMAN, MICHAEL J | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $208,800 | ZCA1 |
| 2016 | Anti-CTGF Therapy for Squamous Cell Lung Cancer1R21CA201486-01 | ONAITIS, MARK | DUKE UNIVERSITY, NC | $207,495 | ZCA1 |
| 2016 | Metabolic Reprogramming of Colon Cancer Liver Metastasis1R21CA201963-01 | LOCASALE, JASON W.SHEN, XILING | DUKE UNIVERSITY, NC | $207,495 | ZCA1 |
| 2016 | Hyperpolarized arginine imaging of inflammatory cells and their inhibition in GBM1R21CA201453-01 | RONEN, SABRINA MIRIAM | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $206,843 | ZCA1 |
| 2016 | Dissecting the molecular and functional role of Sox2 in synovial sarcoma1R21CA194521-01A1 | HOCHEDLINGER, KONRAD | MASSACHUSETTS GENERAL HOSPITAL, MA | $206,635 | ZCA1 |
| 2016 | Chemical biology of superstolides--a novel class of anticancer natural products1R21CA204836-01 | JIN, ZHENDONGLIU, JUN O. | UNIVERSITY OF IOWA, IA | $206,296 | ZCA1 |
| 2016 | Oncogenic role of the ICK-GSK3beta signaling pathway1R21CA195273-01A1 | FU, ZHENG | UNIVERSITY OF VIRGINIA, VA | $206,190 | ZCA1 |
| 2016 | Enhancing the abscopal effect in cancer treatment by immune modulation1R21CA195075-01A1 | WEICHSELBAUM, RALPH R | UNIVERSITY OF CHICAGO, IL | $206,190 | ZCA1 |
| 2016 | Androgen Receptor: A Key Regulator of TRAIL Resistance in Breast Cancer?1R21CA193271-01A1 | TU, YAPING | CREIGHTON UNIVERSITY, NE | $204,515 | ZCA1 |
| 2016 | Mouse model to study dependence of pancreatic cancer on Pik3ca for progression1R21CA194836-01A1 | LIN, RICHARD Z | STATE UNIVERSITY NEW YORK STONY BROOK, NY | $204,076 | ZCA1 |
| 2016 | The Ape1-NPM1 Axis and Telomere Maintenance1R21CA191856-01A1 | DEMPLE, BRUCE F. | STATE UNIVERSITY NEW YORK STONY BROOK, NY | $204,076 | ZCA1 |
| 2016 | Evolving Model of Cancer Susceptibility Testing: Clinical Decisions & Outcomes1R21CA194965-01A1 | PESHKIN, BETH NSCHWARTZ, MARC D | GEORGETOWN UNIVERSITY, DC | $202,928 | ZCA1 |
| 2016 | Autophagy regulation of prostate tumor development1R21CA197887-01A1 | CRAMER, SCOTT DTHORBURN, ANDREW M | UNIVERSITY OF COLORADO DENVER, CO | $202,928 | ZCA1 |
| 2016 | Reducing Colorectal Cancer Disparities: Racial Differences in Colorectal Polyp Profile1R21CA202477-01 | XIRASAGAR, SUDHA | UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA, SC | $202,741 | ZCA1 |
| 2016 | Work Ability in Young Adult Surviviors (WAYS): A Quantitative Investigation1R21CA191989-01A1 | DANHAUER, SUZANNE C | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $202,275 | ZCA1 |
| 2016 | A Stepped-Care Telehealth Approach to Treat Distress in Rural Cancer Survivors1R21CA198237-01A1 | BRENES, GRETCHEN ADANHAUER, SUZANNE C | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $202,275 | ZCA1 |
| 2016 | Efficacy of bariatric surgery to decrease the risk of colorectal cancer in mice1R21CA195002-01A1 | CUMMINGS, BETHANY PAIGE | CORNELL UNIVERSITY, NY | $202,275 | ZCA1 |
| 2016 | Alternative exercise modalities to improve skeletal muscle function in cancer survivors1R21CA191532-01A1 | TOTH, MICHAEL J | UNIVERSITY OF VERMONT & ST AGRIC COLLEGE, VT | $201,460 | ZCA1 |
| 2016 | Post-transplant Cutaneous Squamous Cell Carcinoma and Macrophage Migration Inhibitory Factor1R21CA198024-01A1 | OBERYSZYN, TATIANA M | OHIO STATE UNIVERSITY, OH | $200,970 | ZCA1 |
| 2016 | Exploring IL-36gamma as a new tumor immune therapy1R21CA205727-01 | LU, BINFENG | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $200,970 | ZCA1 |
| 2016 | Immunological miRNA biomarkers for diagnosis of lung cancer1R21CA205746-01 | JIANG, FENG | UNIVERSITY OF MARYLAND BALTIMORE, MD | $200,970 | ZCA1 |
| 2016 | Examining the role of normal hematopoiesis in supporting incipient myelodysplasia1R21CA205828-01 | PERKINS, ARCHIBALD S. | UNIVERSITY OF ROCHESTER, NY | $200,807 | ZCA1 |
| 2016 | A computational framework for statistical analysis of ribosome profiling data1R21CA202960-01 | LAREAU, LIANA FAYE | UNIVERSITY OF CALIFORNIA BERKELEY, CA | $200,441 | ZCA1 |
| 2016 | Carcinoma Cell Hyaluronan as a Therapeutic Target in Metastasis1R21CA205455-01 | WOOD, DAVID KEVIN | UNIVERSITY OF MINNESOTA, MN | $200,345 | ZCA1 |
| 2016 | Hedgehog signaling as a tool in the reversal of 5-FU resistance by inhibiting Thymidylate Synthase transcription in colorectal cancer1R21CA202384-01 | ROBBINS, DAVID J | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $200,318 | ZCA1 |
| 2016 | Develop and Apply a Novel Genome-wide Mendelian Randomization Method to Examine Relationship between Obesity and Lung Cancer1R21CA202529-01 | HO, GLORIA YUEN FUNWANG, TAO | ALBERT EINSTEIN COLLEGE OF MEDICINE, INC, NY | $199,967 | ZCA1 |
| 2016 | Mechanisms of c-CBL Regulation in Cutaneous T-Cell Lymphoma (CTCL)1R21CA206104-01 | WOOD, GARY S | UNIVERSITY OF WISCONSIN-MADISON, WI | $199,665 | ZCA1 |
| 2016 | New HuR inhibitor against pancreatic cancer EMT and CSCs1R21CA198265-01A1 | CHEN, QI | UNIVERSITY OF KANSAS MEDICAL CENTER, KS | $199,665 | ZCA1 |
| 2016 | Novel, orally available ATM inhibitor for glioma conformal radiosensitization1R21CA194789-01A1 | VALERIE, KRISTOFFER CARL | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $199,013 | ZCA1 |
| 2016 | Splicing factors and RNA processing alternations: exploring new players in glioblastoma development1R21CA205475-01 | PENALVA, LUIZ OTAVIO | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX | $199,013 | ZCA1 |
| 2016 | Immunotoxins based on the IgG response to autologous antigens in cancer patients1R21CA198657-01A1 | DESSAIN, SCOTT KENDALL | LANKENAU INSTITUTE FOR MEDICAL RESEARCH, PA | $198,997 | ZCA1 |
| 2016 | Regulation of epithelial-mesenchymal transition and stem cell activity by PTEN in breast cancer1R21CA201715-01 | LI, SHAOHUA | RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL, NJ | $198,474 | ZCA1 |
| 2016 | Rebuilding T cells for Cancer Immunodeficiencies1UH2CA205869-01 | WALSH, SCOTT T | UNIV OF MARYLAND, COLLEGE PARK, MD | $198,360 | ZCA1 |
| 2016 | Second generation MIBG analogs that cotarget DNA for high risk neuroblastoma1R21CA187548-01A1 | BARANOWSKA-KORTYLEWICZ, JANINA | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $196,403 | ZCA1 |
| 2016 | Genetic and Environmental Etiology of Familial Small Intestinal Carcinoid Cancer1R21CA205796-01 | NEKLASON, DEBORAH WOOD | UNIVERSITY OF UTAH, UT | $196,402 | ZCA1 |
| 2016 | SIRT5 as a Therapeutic Target in Acute Myeloid Leukemia1R21CA205936-01 | DEININGER, MICHAEL W. | UNIVERSITY OF UTAH, UT | $196,402 | ZCA1 |
| 2016 | Targeting insulin receptor splicing for treatment of rhabdomyosarcoma1R21CA195324-01A1 | CHANDLER, DAWN S | RESEARCH INST NATIONWIDE CHILDREN'S HOSP, OH | $196,022 | ZCA1 |
| 2016 | Predictive cancer biomarkers: Design and analysis of reproducibility studies1R21CA201207-01 | DOBBIN, KEVIN KSONG, XIAO | UNIVERSITY OF GEORGIA, GA | $195,750 | ZCA1 |
| 2016 | Functions of histone variants in castration-resistance prostate cancer1R21CA198820-01A1 | ISHOV, ALEXANDER M | UNIVERSITY OF FLORIDA, FL | $195,750 | ZCA1 |
| 2016 | Statistical Detection and Biochemical Classification of Cancer Driver Mutation Patterns in Biological Networks1R21CA205778-01 | MOSELEY, HUNTER NATHANIELWANG, CHI | UNIVERSITY OF KENTUCKY, KY | $195,368 | ZCA1 |
| 2016 | Role of EMSY protein complexes in the FA DNA repair pathway1R21CA194871-01A1 | SOBECK, ALEXANDRA THERESIA | UNIVERSITY OF MINNESOTA, MN | $195,119 | ZCA1 |
| 2016 | Toward identification of a family of novel NF-kB inducers1R21CA194868-01A1 | MIYAMOTO, SHIGEKI | UNIVERSITY OF WISCONSIN-MADISON, WI | $195,054 | ZCA1 |
| 2016 | Big data approach for correlating gut microbiota with epithelial methylation pattern1R21CA195251-01A1 | MAI, VOLKERPROSPERI, MATTIA | UNIVERSITY OF FLORIDA, FL | $194,521 | ZCA1 |
| 2016 | Fibroblast-macrophage interactions induce a tumor-promoting microenvironment1R21CA185691-01A1 | KELLY, THOMAS JOSEPHPOST, STEVEN | UNIV OF ARKANSAS FOR MED SCIS, AR | $194,445 | ZCA1 |
| 2016 | Msi2 regulates the aggressiveness of Non-Small Cell Lung Cancer (NSCLC)1R21CA191425-01A1 | GOLEMIS, ERICA A. | RESEARCH INST OF FOX CHASE CAN CTR, PA | $194,119 | ZCA1 |
| 2016 | BRCA1 interacting proteins important for DNA repair1R21CA198228-01A1 | FREITAS, MICHAEL A.PARVIN, JEFFREY D | OHIO STATE UNIVERSITY, OH | $192,514 | ZCA1 |
| 2016 | Chemoprevention of breast cancer with rexinoids that inhibit obesity-induced metabolic syndrome1R21CA195394-01A1 | ATIGADDA, VENKATRAM REDDYCORIC, TATJANA | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $191,835 | ZCA1 |
| 2016 | Developing Therapy for the Treatment of Cholangiocarcinoma1R21CA205501-01 | YOON, KARINA J | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $191,835 | ZCA1 |
| 2016 | Engineered Microenvironments to Study Heterogeneity and Stemness in Breast Cancer1R21CA195016-01A1 | YOON, EUISIK | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $191,765 | ZCA1 |
| 2016 | Auger Electron Radiotherapy of Late-Stage, Castration-Resistant Prostate Cancer using a Brominated Dihydrotestosterone Analogue1R21CA191913-01A1 | BEATTIE, BRADLEY JVEACH, DARREN R | SLOAN-KETTERING INST CAN RESEARCH, NY | $191,291 | ZCA1 |
| 2016 | Prevention of Depression in Head and Neck Cancer1R21CA197023-01A1 | IRWIN, SCOTT A | CEDARS-SINAI MEDICAL CENTER, CA | $190,313 | ZCA1 |
| 2016 | Cbx-3/HP-1gamma deficiency confers anti-tumor immunity1R21CA198263-01A1 | THAI, TO-HA | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $188,138 | ZCA1 |
| 2016 | High-Throughput Functional Annotation of Fusion Gene Cancer Drivers1R21CA198320-01A1 | SCOTT, KENNETH L. | BAYLOR COLLEGE OF MEDICINE, TX | $187,386 | ZCA1 |
| 2016 | Melanoma suppressing functions of carcinoma oncogene FOXQ11R21CA202162-01 | NIKIFOROV, MIKHAIL | ROSWELL PARK CANCER INSTITUTE CORP, NY | $186,506 | ZCA1 |
| 2016 | Sphingolipid-Based Anti-Angiogenic Chemosensitization1R21CA198586-01A1 | KOLESNICK, RICHARD N | SLOAN-KETTERING INST CAN RESEARCH, NY | $186,398 | ZCA1 |
| 2016 | Linking macrophages to gut microbiota in obesity-enhanced colon cancer1R21CA191966-01A1 | MURPHY, ELIZABETH ANGELAROBINSON, CORY MICHAEL | UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA, SC | $185,028 | ZCA1 |
| 2016 | Defining the Germline Genomic Landscape of a Novel GIST Multi-tumor Syndrome1R21CA192072-01A1 | SICKLICK, JASON KEITH | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $184,459 | ZCA1 |
| 2016 | Mechanisms of Orthotopic Human Colorectal Cancer Growth in Immunocompetent Mice1R21CA201829-01 | LONGMAN, RANDY S | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $184,331 | ZCA1 |
| 2016 | Roles of formins in breast cancer invasion1R21CA205262-01 | HODGSON, LOUIS | ALBERT EINSTEIN COLLEGE OF MEDICINE, INC, NY | $181,613 | ZCA1 |
| 2016 | Telomere dysfunction and genome instability in familial melanoma1R21CA200506-01 | CHANG, SANDY S | YALE UNIVERSITY, CT | $181,522 | ZCA1 |
| 2016 | Measurement of prognostic understanding in patients with advanced cancer1R21CA186932-01A1 | ROSENFELD, BARRY | FORDHAM UNIVERSITY, NY | $179,146 | ZCA1 |
| 2016 | Deep learning for representation of codes used for SEER-Medicare claims research1R21CA202130-01 | EGLESTON, BRIAN LVUCETIC, SLOBODAN | RESEARCH INST OF FOX CHASE CAN CTR, PA | $178,072 | ZCA1 |
| 2016 | Advanced Diffusion Imaging of Breast Cancer1R21CA201834-01 | BOLAN, PATRICK JOHN | UNIVERSITY OF MINNESOTA, MN | $177,690 | ZCA1 |
| 2016 | Novel role of the polycomb repressive complex PRC2/EZH2 in glioblastoma1R21CA198648-01A1 | IYER, VISHWANATH R | UNIVERSITY OF TEXAS AT AUSTIN, TX | $177,027 | ZCA1 |
| 2016 | Super-Localization Ultrasound Imaging with Targeted Laser-activated Nanodetectors1R21CA197409-01A1 | LUKE, GEOFFREY P. | DARTMOUTH COLLEGE, NH | $176,175 | ZCA1 |
| 2016 | Defining the urban-rural continuum and distinguishing rural differences to prevent tobacco use1R21CA205589-01 | STILLMAN, FRANCES ALENAWEWERS, MARY ELLEN | NATIONAL OPINION RESEARCH CENTER, IL | $175,200 | ZCA1 |
| 2016 | Role of the pentose phosphate pathway in tumorigenesis1R21CA195360-01A1 | YANG, XIAOLU | UNIVERSITY OF PENNSYLVANIA, PA | $175,088 | ZCA1 |
| 2016 | Identifying Mechanisms of p53 and Rb Tumor Suppression In Small Cell Lung Cancer1R21CA205340-01 | FELDSER, DAVID | UNIVERSITY OF PENNSYLVANIA, PA | $174,816 | ZCA1 |
| 2016 | Molecular origin and evolution of HPV inactive head and neck cancers1R21CA201853-01 | PIRISI-CREEK, LUCIA AMELIA | UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA, SC | $174,218 | ZCA1 |
| 2016 | Novel Point-of-Care Tool to Predict Response to Sorafenib in Hepatocellular Carcinoma1R21CA190945-01A1 | KASEB, AHMED | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $174,000 | ZCA1 |
| 2016 | Couple-based meditation program for patients with metastatic lung cancer and their partners1R21CA191711-01A1 | MILBURY, KATHRIN | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $174,000 | ZCA1 |
| 2016 | Targeted Molecular Imaging of Cell Death in Ovarian Cancer1R21CA181994-01A1 | LU, ZHENMILLWARD, STEVEN W | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $174,000 | ZCA1 |
| 2016 | Defining the role of FAM83A in Herceptin-resistant breast cancer1R21CA194902-01A1 | JACKSON, MARK W. | CASE WESTERN RESERVE UNIVERSITY, OH | $172,369 | ZCA1 |
| 2016 | The cell of origin of breast cancer metastasis1R21CA202227-01 | LI, YI | BAYLOR COLLEGE OF MEDICINE, TX | $172,369 | ZCA1 |
| 2016 | Interferon-beta inhibits the expansion of cancer stem-cells1R21CA198808-01A1 | JACKSON, MARK W.STARK, GEORGE ROBERT | CASE WESTERN RESERVE UNIVERSITY, OH | $172,369 | ZCA1 |
| 2016 | Tumor cytonemes, a new target for tumor suppression1R21CA205580-01 | KORNBERG, THOMAS B. | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $172,369 | ZCA1 |
| 2016 | Mechanism by which H2S-producing bacteria influence development of colorectal cancer1R21CA195226-01A1 | JOBIN, CHRISTIAN | UNIVERSITY OF FLORIDA, FL | $171,275 | ZCA1 |
| 2016 | Genomic and molecular dissection of the collective invasion pack1R21CA201744-01 | MARCUS, ADAM I. | EMORY UNIVERSITY, GA | $169,650 | ZCA1 |
| 2016 | Restricting radiosensitization through ErbB targeted antibody drug conjugates1R21CA205765-01 | ADVANI, SUNIL J | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $168,563 | ZCA1 |
| 2016 | Exploring high-does testosterone as a potential treatment for abiraterone-resistant prostate cancer1R21CA194798-01A1 | COREY, EVA | UNIVERSITY OF WASHINGTON, WA | $168,019 | ZCA1 |
| 2016 | Reducing false positives during interpretations of ultrasound examinations for breast cancer screening1R21CA203684-01 | GUR, DAVID | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $167,475 | ZCA1 |
| 2016 | MicroRNA and Transcription Factor Co-regulation in Cancer1R21CA196508-01A1 | ZHAO, ZHONGMING | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | $167,475 | ZCA1 |
| 2016 | Unraveling the Function of RNA-Binding proteins in B-lympoblastic Leukemia1R21CA197441-01A1 | RAO, DINESH S | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $167,475 | ZCA1 |
| 2016 | Common hTERT Promoter Mutations Represent a Novel Therapeutic Target1R21CA191663-01A1 | MILLER, DONALD M. | UNIVERSITY OF LOUISVILLE, KY | $167,023 | ZCA1 |
| 2016 | A novel IL-2 biologic and tumor immunity1R21CA195334-01A1 | MALEK, THOMAS R | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $166,931 | ZCA1 |
| 2016 | Novel Animal Models for Functional Analysis of Protein Phosphorylation in Breast Cancer Progression.1R21CA187303-01A1 | DAI, ZONGHAN | TEXAS TECH UNIVERSITY HEALTH SCIS CENTER, TX | $166,388 | ZCA1 |
| 2016 | Searching for Genetic Basis for Metastasis of Differentiated Thyroid Cancer1R21CA201735-01 | LARGAESPADA, DAVID ANDREW | UNIVERSITY OF MINNESOTA, MN | $166,243 | ZCA1 |
| 2016 | Inhibitors of B-raf through the Dimerization Interface1R21CA191899-01A1 | MCINNES, CAMPBELL | UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA, SC | $162,984 | ZCA1 |
| 2016 | A Small-Molecule Inhibitor of the Terminal Steps for Intracrine Androgen Synthesis in Advanced Prostate Cancer1R21CA205108-01 | MOHLER, JAMES L | ROSWELL PARK CANCER INSTITUTE CORP, NY | $162,075 | ZCA1 |
| 2016 | Magi2 in aggressive prostate cancer1R21CA195313-01A1 | MARKER, PAUL C | UNIVERSITY OF WISCONSIN-MADISON, WI | $161,777 | ZCA1 |
| 2016 | Modifier of Cancer Sensitivity to Statins1R21CA198327-01A1 | MU, DAVID | EASTERN VIRGINIA MEDICAL SCHOOL, VA | $159,319 | ZCA1 |
| 2016 | Formation of a Neocentromere at a DSB Site1R21CA205659-01 | KITAGAWA, KATSUMI | RESEARCH INST NATIONWIDE CHILDREN'S HOSP, OH | $73,834 | ZCA1 |
| 2016 | Prevention of genomic instability by a scavenger of bifunctional electrophiles1R21CA201856-01 | OATES, JOHN ALEXANDER | VANDERBILT UNIVERSITY, TN | $57,361 | ZCA1 |
| 2016 | Promoting Smoking Cessation Among Youth Exiting Foster Care1R21CA205190-01 | BRACISZEWSKI, JORDAN MICHEL | PACIFIC INSTITUTE FOR RES AND EVALUATION, MD | $29,841 | ZCA1 |
| 2016 | Metabolic regulation of T-ALL cellular proliferation and lifespan1R21CA194829-01A1 | RATHMELL, JEFFREY C. | VANDERBILT UNIVERSITY, TN | $20,251 | ZCA1 |
| 2016 | An epigenetic link from CXCL12-CXCR4 axis through nuclear LASP-1 in breast cancer1R21CA202176-01 | RAMAN, DAYANIDHI | VANDERBILT UNIVERSITY, TN | $7,177 | ZCA1 |
| 2016 | PD-1 Blockade and Neoantigen-Specific T Cell Immunity1R21CA205794-01 | LINETTE, GERALD P | WASHINGTON UNIVERSITY, MO | $4,095 | ZCA1 |
| 2015 | Facilitating Informed Decisions for Contralateral Prophylactic Mastectomy1R21CA187643-01A1 | KIRSTEIN, LAURIEMANNE, SHARON L | RBHS -CANCER INSTITUTE OF NEW JERSEY, NJ | $259,496 | ZCA1 |
| 2015 | Elucidating neural crest-like reprogramming in melanoma1R21CA191742-01 | FUKUNAGA-KALABIS, MIZUHO | WISTAR INSTITUTE, PA | $255,511 | ZCA1 |
| 2015 | eIF2a phosphorylation as a novel druggable target in CRPC1R21CA190588-01 | KAUFMAN, RANDAL J.WOLF, DIETER A | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA | $254,475 | ZCA1 |
| 2015 | RNF125 controls melanoma response to B-RAF inhibitor and immune checkpoint therapy1R21CA198468-01 | KIM, HYUNGSOO | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA | $254,475 | ZCA1 |
| 2015 | Single-molecule studies of BRCA1-BACH1 mechanism in genomic integrity1R21CA187612-01A1 | ROTHENBERG, ELI | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $253,893 | ZCA1 |
| 2015 | Novel Approach to Facilitate Decisions in Patients w/ Muscle Invasive Bladder CA1R21CA176551-01A1 | DIEFENBACH, MICHAEL AGALSKY, MATTHEW | FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH, NY | $252,477 | ZCA1 |
| 2015 | Diet patterns, aspirin use, obesity and multiple myeloma: a prospective analysis1R21CA198239-01 | BIRMANN, BRENDA M | BRIGHAM AND WOMEN'S HOSPITAL, MA | $252,155 | ZCA1 |
| 2015 | Dissection of Tumor Evolution Using Patient-Derived Xenografts1R21CA191848-01A1 | CHUANG, JEFFREY HSU-MIN | JACKSON LABORATORY, ME | $251,699 | ZCA1 |
| 2015 | Computational pathology to predict breast cancer risk in benign breast disease1R21CA187642-01A1 | BECK, ANDREW HTAMIMI, RULLA M | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $247,844 | ZCA1 |
| 2015 | Salivary Metabolite Biomarkers for Diagnosing Nodal Metastasis in Oral Cancer1R21CA187151-01A1 | CHEN, CHU | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $247,399 | ZCA1 |
| 2015 | Development of a Novel System to Capture DNA-associated Proteins1R21CA195012-01 | LAZZERINI DENCHI, EROS | SCRIPPS RESEARCH INSTITUTE, THE, CA | $247,298 | ZCA1 |
| 2015 | Antibody Fingerprinting of Triple Negative Breast Cancer by High Throughput FACS1R21CA198595-01 | FELDING, BRUNIE H.SMIDER, VAUGHN VASIL | SCRIPPS RESEARCH INSTITUTE, THE, CA | $247,298 | ZCA1 |
| 2015 | Genomic studies for understanding etiology of esophageal adenocarcinoma1R21CA197502-01 | DAI, JAMES | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $246,080 | ZCA1 |
| 2015 | LMTK3 inhibitors for the treatment of breast cancer1R21CA191351-01A1 | NEFZI, ADELPIEDRAFITA, FRANCISCO JAVIER | TORREY PINES INST FOR MOLECULAR STUDIES, FL | $239,730 | ZCA1 |
| 2015 | Novel Role of Honokiol in Preventing Cancer during Immune Suppression1R21CA191735-01A1 | PAL, SOUMITRO | BOSTON CHILDREN'S HOSPITAL, MA | $236,488 | ZCA1 |
| 2015 | 5-hydroxymethylcytosine in HPV(+) and HPV(-) oral and oropharyngeal cancers1R21CA187537-01A1 | SARTOR, MAUREEN AGNES | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $235,466 | ZCA1 |
| 2015 | TDG as a novel target to enhance gemcitabine killing of pancreatic cancer cells1R21CA191956-01A1 | BELLACOSA, ALFONSOYEN, TIMOTHY | RESEARCH INST OF FOX CHASE CAN CTR, PA | $232,943 | ZCA1 |
| 2015 | Resting-state fMRI for Language Mapping in Brain Tumor Patients1R21CA198740-01 | GOLBY, ALEXANDRA JTIE, YANMEI | BRIGHAM AND WOMEN'S HOSPITAL, MA | $231,474 | ZCA1 |
| 2015 | Local control of anti-tumor/anti-self reactivity in low-affinity ACT1R21CA192246-01 | SCHOENBERGER, STEPHEN PHILIP | LA JOLLA INSTITUTE FOR IMMUNOLOGY, CA | $230,985 | ZCA1 |
| 2015 | Influence of germ line genetic variation on myeloma progression and survival1R21CA191896-01 | VACHON, CELINE MZIV, ELAD | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $230,502 | ZCA1 |
| 2015 | Defining oncogenic capacities of PAK7 mutations in human cancer1R21CA184656-01A1 | HANSEN, STEEN HENNING | BOSTON CHILDREN'S HOSPITAL, MA | $230,333 | ZCA1 |
| 2015 | Identifying CDK4 and CDK6 substrates in cancers and cancer therapy1R21CA187324-01A1 | CLURMAN, BRUCE E | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $229,680 | ZCA1 |
| 2015 | Function-blocking anti-ADAM protease antibodies for inhibition of tumorigenesis1R21CA185930-01A1 | NIKOLOV, DIMITAR B | SLOAN-KETTERING INST CAN RESEARCH, NY | $229,550 | ZCA1 |
| 2015 | Defining a novel subtype of luminal-TP53 mutant breast cancer with poor prognosis1R21CA195365-01 | REIS-FILHO, JORGESHEN, RONGLAIWEIGELT, BRITTA | SLOAN-KETTERING INST CAN RESEARCH, NY | $229,550 | ZCA1 |
| 2015 | The derivation of pituitary cells from human ES cells1R21CA176700-01A1 | TABAR, VIVIANE | SLOAN-KETTERING INST CAN RESEARCH, NY | $229,550 | ZCA1 |
| 2015 | Genetic Predictors of Response to mTOR inhibitors in advanced Renal Cancer1R21CA191687-01 | CHOUEIRI, TONIKWIATKOWSKI, DAVID J. | DANA-FARBER CANCER INST, MA | $229,296 | ZCA1 |
| 2015 | Safety and anti-cancer efficacy of FACT inactivation in mice1R21CA198395-01 | GUROVA, KATERINA V | ROSWELL PARK CANCER INSTITUTE CORP, NY | $229,028 | ZCA1 |
| 2015 | Investigation of systemic lymphatic uptake of macromolecules1R21CA191979-01 | PAPISOV, MIKHAIL I | MASSACHUSETTS GENERAL HOSPITAL, MA | $227,070 | ZCA1 |
| 2015 | Internet-Assisted Cognitive Behavior Intervention for Targeted Therapy Fatigue1R21CA191594-01 | JACOBSEN, PAUL B | H. LEE MOFFITT CANCER CTR & RES INST, FL | $224,936 | ZCA1 |
| 2015 | 4C and Genome Editing for Causal SNP and Gene Discovery at Cancer Risk Loci1R21CA191725-01A1 | FREEDMAN, MATTHEW L | DANA-FARBER CANCER INST, MA | $223,181 | ZCA1 |
| 2015 | Novel therapeutic strategies targeting conformational plasticity of type I MAGE1R21CA191898-01 | CHO, HEARN JAYOSMAN, ROMAN | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $223,096 | ZCA1 |
| 2015 | Psoralens and melanoma1R21CA198216-01 | CHO, EUNYOUNG | BROWN UNIVERSITY, RI | $221,938 | ZCA1 |
| 2015 | Autophagy, mTOR inhibitors and phenformin in hepatocellular carcinoma1R21CA191814-01A1 | MERCER, CAROL | UNIVERSITY OF CINCINNATI, OH | $221,653 | ZCA1 |
| 2015 | Melanoma prevention by MC1R selective small peptide analogs of alpha MSH1R21CA191761-01A1 | ABDEL-MALEK, ZALFA | UNIVERSITY OF CINCINNATI, OH | $221,595 | ZCA1 |
| 2015 | Ephrin and Eph regulation of prostate stem cells - Resubmission - 11R21CA175834-01A1 | MOSCATELLI, DAVID A | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $221,198 | ZCA1 |
| 2015 | Rapid Determination of Phenotypic Responses Across Cancer Cell Lines1R21CA198543-01 | POSSEMATO, RICHARD LEWIS | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $221,198 | ZCA1 |
| 2015 | Prevention of COX-2 Derived DNA and Histone Modifications in Cancer1R21CA187495-01A1 | OATES, JOHN ALEXANDER | VANDERBILT UNIVERSITY, TN | $221,049 | ZCA1 |
| 2015 | Translocations And Their Widespread Impact on Gene Regulation1R21CA188968-01A1 | SKOK, JANE AMANDA | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $220,825 | ZCA1 |
| 2015 | TBK1 mediated regulation of E2F1 as a therapeutic target in non-small cell lung cancer1R21CA187795-01A1 | CHELLAPPAN, SRIKUMAR P. | H. LEE MOFFITT CANCER CTR & RES INST, FL | $219,893 | ZCA1 |
| 2015 | Specific skeletal targeting of MMP-2 for the treatment of multiple myeloma1R21CA191981-01A1 | HAZLEHURST, LORI ALYNCH, CONOR C | H. LEE MOFFITT CANCER CTR & RES INST, FL | $219,893 | ZCA1 |
| 2015 | Development of the Malignancy-Risk Gene Signature Assay for Predicting Breast Cancer Risk1R21CA198762-01 | LEE, MARIE CATHERINE | H. LEE MOFFITT CANCER CTR & RES INST, FL | $219,893 | ZCA1 |
| 2015 | CUTTING EDGE LINEAGE TRACKING OF TUMOR-EDUCATED IMMUNE CELLS1R21CA191428-01 | KRUMMEL, MATTHEW F | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $219,513 | ZCA1 |
| 2015 | Optimizing risk stratification to manage early stage bladder cancer1R21CA191610-01 | MCMULLEN, CARMIT KURNNIELSEN, MATTHEW E. | KAISER FOUNDATION RESEARCH INSTITUTE, CA | $219,261 | ZCA1 |
| 2015 | Pediatric Cancer Interdisciplinary Team Training for Regoaling CARE Discussions1R21CA198049-01 | FEUDTNER, JOHN CHRIS | CHILDREN'S HOSP OF PHILADELPHIA, PA | $219,240 | ZCA1 |
| 2015 | Imaging endogenously produced tumor derived micro vesicles1R21CA190344-01 | PITTET, MIKAEL | MASSACHUSETTS GENERAL HOSPITAL, MA | $218,257 | ZCA1 |
| 2015 | Targeting an MT1-MMP/MMP2 axis in melanoma by a novel MT1-MMP/MMP2 inhibitor1R21CA187695-01A1 | BEDOGNI, BARBARA | CASE WESTERN RESERVE UNIVERSITY, OH | $217,926 | ZCA1 |
| 2015 | Oxygen Microbubbles for Overcoming Hypoxic Tumor Resistance to Radiotherapy1R21CA190926-01A1 | EISENBREY, JOHNO'KANE, PATRICK | THOMAS JEFFERSON UNIVERSITY, PA | $217,689 | ZCA1 |
| 2015 | Metabolic Drivers of Melanoma Initiation, Progression and Therapy Response1R21CA191364-01 | WAJAPEYEE, NARENDRA | YALE UNIVERSITY, CT | $217,283 | ZCA1 |
| 2015 | Progesterone Augmentation for Smoking Cessation in Women1R21CA198187-01 | SOFUOGLU, MEHMETYONKERS, KIMBERLY A | YALE UNIVERSITY, CT | $217,283 | ZCA1 |
| 2015 | SYNERGIZING PRO-APOPTOTIC AND CAR-T CELL IMMUNOTHERAPY FOR MANTLE CELL LYMPHOMA1R21CA198561-01 | KATZ, SAMUEL G | YALE UNIVERSITY, CT | $217,283 | ZCA1 |
| 2015 | A Problem-Solving Intervention for Family Caregivers in Palliative Oncology1R21CA191165-01A1 | WASHINGTON, KARLA | UNIVERSITY OF MISSOURI-COLUMBIA, MO | $217,280 | ZCA1 |
| 2015 | The genetics of hepatosplenic T cell lymphoma1R21CA195173-01 | DAVE, SANDEEP | DUKE UNIVERSITY, NC | $217,108 | ZCA1 |
| 2015 | Adjuvant Lorazepam for Agitated Delirium in the Palliative Care Unit1R21CA186000-01A1 | HUI, DAVID | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $216,664 | ZCA1 |
| 2015 | Detection of 5-hmC as a Novel Screening Biomarker for Pancreatic Cancer1R21CA187869-01A1 | HOU, LIFANGZHANG, WEI | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $216,485 | ZCA1 |
| 2015 | T cell TGF-beta signaling as a therapeutic target for pediatric brain tumors1R21CA178605-01A1 | TOWN, TERRENCE C | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $215,325 | ZCA1 |
| 2015 | Therapeutic targeting of the B-cell lymphoma associated mutation MYD88-L265P1R21CA191726-01 | SNYDER, GREG ALLEN | UNIVERSITY OF MARYLAND BALTIMORE, MD | $215,284 | ZCA1 |
| 2015 | Beneficial effects of Honokiol against liver cancer1R21CA185943-01A1 | SAXENA, NEERAJ KUMAR | UNIVERSITY OF MARYLAND BALTIMORE, MD | $215,284 | ZCA1 |
| 2015 | Identification and Targeting Therapy Resistant Osteosarcoma1R21CA185036-01A1 | MAKI, CARL G | RUSH UNIVERSITY MEDICAL CENTER, IL | $215,244 | ZCA1 |
| 2015 | Feasibility of Molecular Cytology for the Management of Barrett's Esophagus1R21CA187753-01A1 | GODFREY, TONY E | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $214,371 | ZCA1 |
| 2015 | Discoidin Domain Receptors: Novel Players in Pancreatitis and Pancreatic Preneoplasia1R21CA191347-01 | CRAWFORD, HOWARD C.FRIDMAN, RAFAEL A. | WAYNE STATE UNIVERSITY, MI | $213,888 | ZCA1 |
| 2015 | Overcoming the resistance to anti-angiogenesis therapy1R21CA191970-01 | RAHIMI, NADER | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $213,629 | ZCA1 |
| 2015 | Deciphering the pathogenesis of pediatric high-grade gliomas1R21CA192003-01 | LI, GUO-MIN | UNIVERSITY OF KENTUCKY, KY | $212,244 | ZCA1 |
Showing the 200 most recent of 517 awards.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.